The effects of tocotrienols intake on obesity, blood pressure, inflammation, liver and glucose biomarkers: a meta-analysis of randomized controlled trials
- 12 September 2022
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Food Science and Nutrition
- Vol. 62 (26) , 7154-7167
Abstract
The objective of this study is to accomplish a systematic review and meta-analysis of all randomized controlled trials that dissected the influence of tocotrienol supplementation on various anthropometric and cardiometabolic indices in all individuals, irrespective of health condition. This research was carried out in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement guidelines. 17 eligible articles were included in the final quantitative analysis. Current study revealed that tocotrienol consumption was not associated with CRP, WC, MDA, BMI, IL-6, HbA1C, ALT, AST, creatinine TNF-alpha, FPG, BW, DBP, and SBP. We did observe an overall increase in BW (SMD: 0.063 kg, 95% CI: -0.200, 0.327, p = 0.637) and DBP (SMD: 0.249 mmHg, 95% CI: 0.053, 0.446, p = 0.013). In addition, a significant reduction in SBP was observed (SMD: -0.616 mmHg, 95% CI: -1.123, -0.110, p = 0.017). In summary, our meta-analysis revealed that tocotrienol consumption was associated with increase in BW and DBP and decrease in SBP. Significant associations were not observed for other outcomes.Keywords
This publication has 40 references indexed in Scilit:
- Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trialNutrition Journal, 2013
- Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled studyNutrition & Metabolism, 2011
- Multifaceted role of tocotrienols in cardioprotection supports their structure: function relationGenes & Nutrition, 2011
- Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseasesBiochemical Pharmacology, 2010
- Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trialBreast Cancer Research, 2010
- Attenuation of diabetic nephropathy by tocotrienol: Involvement of NFkB signaling pathwayLife Sciences, 2009
- Role of TNF-α in vascular dysfunctionClinical Science, 2009
- C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based CohortClinical Chemistry, 2008
- The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemiaAtherosclerosis, 2005
- Effect of γ-Tocotreenol on Blood Pressure, Lipid Peroxtoation and Total Antioxtoant Status in Spontaneously Hypertensive Rats (SHR)Clinical and Experimental Hypertension, 1999